UK markets open in 48 minutes
NIKKEI 225
37,636.54 -823.54 (-2.14%) HANG SENG
17,215.29 +14.02 (+0.08%) CRUDE OIL
82.92 +0.11 (+0.13%) GOLD FUTURES
2,330.20 -8.20 (-0.35%) DOW
38,460.92 -42.77 (-0.11%) Bitcoin GBP
51,510.25 -1,910.58 (-3.58%)
Advanced Oncotherapy plc (AVO.L)
LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
At close: 04:23PM BST
Currency in GBp
Valuation measures4
| Market cap (intra-day) | 10.44M |
| Enterprise value | 67.68M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 0.17 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -2.77 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.07 |
| 52-week change 3 | -60.31% |
| S&P500 52-week change 3 | 22.64% |
| 52-week high 3 | 0.0870 |
| 52-week low 3 | 0.0000 |
| 50-day moving average 3 | 0.0192 |
| 200-day moving average 3 | 0.0192 |
Share statistics
| Avg vol (3-month) 3 | N/A |
| Avg vol (10-day) 3 | N/A |
| Shares outstanding 5 | 542.57M |
| Implied shares outstanding 6 | 542.57M |
| Float 8 | 212.84M |
| % held by insiders 1 | 47.53% |
| % held by institutions 1 | 17.83% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:25 |
| Last split date 3 | 01 Jul 2016 |
Financial highlights
Currency in GBP.Fiscal year
| Fiscal year ends | 31 Dec 2021 |
| Most-recent quarter (mrq) | 30 Jun 2022 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -11.73% |
| Return on equity (ttm) | -67.34% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -25.05M |
| Net income avi to common (ttm) | -32.6M |
| Diluted EPS (ttm) | -0.0700 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 2.51M |
| Total cash per share (mrq) | 0 |
| Total debt (mrq) | 59.74M |
| Total debt/equity (mrq) | 98.71% |
| Current ratio (mrq) | 1.26 |
| Book value per share (mrq) | 0.14 |
Cash flow statement
| Operating cash flow (ttm) | -26.65M |
| Levered free cash flow (ttm) | -34.96M |
© 2024 Yahoo. All rights reserved.